Literature DB >> 11981060

Prolonged calcium transients and myocardial remodelling in early experimental uraemia.

Aisling C McMahon1, Stephen E Greenwald, Susan M Dodd, Martin J Hurst, Anthony E G Raine.   

Abstract

BACKGROUND: Cardiovascular disease is the most common cause of premature death in patients with end-stage renal disease, possibly due to a specific 'uraemic cardiomyopathy'. This study was designed to investigate the cardiac changes induced by a moderate impairment of renal function in a model of uraemia.
METHODS: Male Wistar rats (n=11) were rendered uraemic by 5/6 nephrectomy or sham operated (n=11). After 4 weeks, cardiac dimensions were measured from fixed tissue sections using a digital image analysis technique. In parallel groups of animals, cardiac myocytes were isolated and studied for evidence of functional changes attributable to uraemia. After steady-state field stimulation at 0.5 Hz, intracellular Ca(2+) handling (using Fura-2) was investigated. Up to 20 consecutive transients were averaged as the extracellular Ca(2+) was increased.
RESULTS: The 5/6 nephrectomy group had a 75% reduction in glomerular filtration rate, and a 2- to 3-fold increase in serum urea and creatinine compared with sham-operated control animals (P<0.0001). However, the blood pressure was found to be similar in each group. Histology of the intact hearts (five pairs) showed a significant increase in tissue cross-sectional area (14%; P<0.04), cross-sectional area of the left ventricle (22%; P<0.04), and a significant increase in left ventricular wall thickness (15%; P<0.03). In the single cardiac cell study, under basal conditions (1-2 mM extra-cellular Ca(2+)) no significant differences in intracellular Ca(2+) were observed, but in high extracellular Ca(2+) the uraemic cells were slower to return to diastolic intracellular Ca(2+) levels (P<0.05).
CONCLUSIONS: The data provide evidence of altered myocardial structure and function in early experimental uraemia. The changes described are consistent with concentric hypertrophy of the left ventricle, which occurs in the absence of hypertension.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11981060     DOI: 10.1093/ndt/17.5.759

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  Mitochondrial dysfunction in uremic cardiomyopathy.

Authors:  David Taylor; Sunil Bhandari; Anne-Marie L Seymour
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

2.  Experimental models of renal disease and the cardiovascular system.

Authors:  Rebecca C Grossman
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

Review 3.  Reversible Cardiomyopathies.

Authors:  Harsh Patel; Raef Madanieh; Constantine E Kosmas; Satya K Vatti; Timothy J Vittorio
Journal:  Clin Med Insights Cardiol       Date:  2015-05-21

Review 4.  Na+/Ca2+ exchange and Na+/K+-ATPase in the heart.

Authors:  Michael J Shattock; Michela Ottolia; Donald M Bers; Mordecai P Blaustein; Andrii Boguslavskyi; Julie Bossuyt; John H B Bridge; Ye Chen-Izu; Colleen E Clancy; Andrew Edwards; Joshua Goldhaber; Jack Kaplan; Jerry B Lingrel; Davor Pavlovic; Kenneth Philipson; Karin R Sipido; Zi-Jian Xie
Journal:  J Physiol       Date:  2015-03-15       Impact factor: 5.182

Review 5.  Mechanisms and Modulation of Oxidative/Nitrative Stress in Type 4 Cardio-Renal Syndrome and Renal Sarcopenia.

Authors:  Márta Sárközy; Zsuzsanna Z A Kovács; Mónika G Kovács; Renáta Gáspár; Gergő Szűcs; László Dux
Journal:  Front Physiol       Date:  2018-11-26       Impact factor: 4.566

6.  Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212.

Authors:  Márta Sárközy; Renáta Gáspár; Ágnes Zvara; Andrea Siska; Bence Kővári; Gergő Szűcs; Fanni Márványkövi; Mónika G Kovács; Petra Diószegi; László Bodai; Nóra Zsindely; Márton Pipicz; Kamilla Gömöri; Krisztina Kiss; Péter Bencsik; Gábor Cserni; László G Puskás; Imre Földesi; Thomas Thum; Sándor Bátkai; Tamás Csont
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

7.  Association Between High-Sensitivity Cardiac Troponin T and Echocardiographic Parameters in Chronic Kidney Disease: Results From the KNOW-CKD Cohort Study.

Authors:  Eunjeong Kang; Hyunjin Ryu; Jayoun Kim; Joongyub Lee; Kyu-Beck Lee; Dong-Wan Chae; Su Ah Sung; Soo Wan Kim; Curie Ahn; Kook-Hwan Oh
Journal:  J Am Heart Assoc       Date:  2019-09-13       Impact factor: 5.501

8.  Gene expression profiling on global cDNA arrays gives hints concerning potential signal transduction pathways involved in cardiac fibrosis of renal failure.

Authors:  Kerstin Amann; Heidrun Ridinger; Christiane Rutenberg; Eberhard Ritz; Gerhard Mall; Christian Maercker
Journal:  Comp Funct Genomics       Date:  2003

9.  Myocardial dysfunction occurs prior to changes in ventricular geometry in mice with chronic kidney disease (CKD).

Authors:  Pamela D Winterberg; Rong Jiang; Josh T Maxwell; Bo Wang; Mary B Wagner
Journal:  Physiol Rep       Date:  2016-03

10.  Cardiac calcium dysregulation in mice with chronic kidney disease.

Authors:  Hung-Yen Ke; Li-Han Chin; Chien-Sung Tsai; Feng-Zhi Lin; Yen-Hui Chen; Yung-Lung Chang; Shih-Ming Huang; Yao-Chang Chen; Chih-Yuan Lin
Journal:  J Cell Mol Med       Date:  2020-02-16       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.